Ac-225 alphavbeta3-IAC (Advanced Imaging Projects)

N/A

Report date: 2025/03/14 18:11:38
NME

Base Information

Drug NameAc-225 alphavbeta3-IAC (Advanced Imaging Projects)
Drug Alias Nameintegrin alphaVbeta3-targeted therapy (Advanced Imaging Projects)
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvanced Imaging Projects
China Registration ClassN/A

Develop Information

Active CompaniesAdvanced Imaging Projects
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A